{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:42:30Z","timestamp":1784875350354,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det om H\u00e4lsa, Arbetsliv och V\u00e4lf\u00e4rd","doi-asserted-by":"publisher","award":["2014-4753"],"award-info":[{"award-number":["2014-4753"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The longevity for people with intellectual disability (ID) has significantly increased in developed countries during the past decades. Consequently, the incidence of cancer is expected to increase in this group. The aim of the present study was to investigate the prescription of pain medication in older cancer patients with intellectual disability (ID) compared to older patients in the general population, surviving or living with a cancer diagnosis.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This Swedish national registry-based study, included people with ID aged 55\u2009years or older in 2012, and alive at the end of that year (ID cohort, <jats:italic>n<\/jats:italic>\u2009=\u20097936). For comparisons, we used a referent cohort, one-to-one matched with the general population by year of birth and sex (gPop cohort, n\u2009=\u20097936). People with at least one diagnosis of cancer during 2002\u20132012 were identified using the Swedish National Patient Register, resulting in 555 cancer patients with ID and 877 cancer patients from the general population. These two cohorts of cancer patients were compared with respect to prescription of pain medication for the period 2006\u20132012. Outcome data were aggregated so that each patient was categorized as either having or not having at least one prescription of each investigated drug group during the study period, and relative risks (RRs) for prescription were estimated for prescription in the ID cohort vs the gPop cohort.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Cancer patients with ID were less likely than cancer patients in the gPop cohort to have at least one prescription of COX inhibitors (RR 0.61) and weak opioids (RR 0.63). They were, however, more likely to be prescribed paracetamol (RR 1.16), antidepressants (RR 2.09), anxiolytics (RR 2.84), and \u201cother hypnotics, sedatives, and neuroleptics\u201d (RR 1.39). No statistically significant differences between the two cohorts were found for strong opioids, antiepileptics, tricyclic antidepressants, or hypnotics and sedatives.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In the studied cohort of older people surviving or living with cancer, prescriptions for pain-treatment was less common in patients with ID compared to the general population. These results may suggest that pain is not sufficiently treated among cancer patients with ID, a situation that most likely would compromise the quality of life in this group.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-019-6290-0","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T16:02:57Z","timestamp":1572883377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prescription of pain medication among older cancer patients with and without an intellectual disability: a national register study"],"prefix":"10.1186","volume":"19","author":[{"given":"Mikael","family":"Segerlantz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Axmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Gagnemo Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6230-7583","authenticated-orcid":false,"given":"Gerd","family":"Ahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"6290_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1056\/NEJM199403033300902","volume":"330","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592\u20136.","journal-title":"N Engl J Med"},{"key":"6290_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0885-3924(05)80021-1","volume":"5","author":"N Coyle","year":"1990","unstructured":"Coyle N, Adelhardt J, Foley KM, Portenoy RK. Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manag. 1990;5:83\u201393.","journal-title":"J Pain Symptom Manag"},{"key":"6290_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0885-3924(94)90174-0","volume":"9","author":"S Grond","year":"1994","unstructured":"Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manag. 1994;9:372\u201382.","journal-title":"J Pain Symptom Manag"},{"key":"6290_CR4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/0885-3924(93)90190-7","volume":"8","author":"W Stein","year":"1993","unstructured":"Stein W, Miech R. Cancer pain in the elderly hospice patient. J Pain Symptom Manag. 1993;8:474\u201382.","journal-title":"J Pain Symptom Manag"},{"key":"6290_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11912-016-0557-2","volume":"18","author":"L Balduccin","year":"2016","unstructured":"Balduccin L, Dolan D. Palliative Care of Cancer in the older patient. Curr Oncol Rep. 2016;18:70.","journal-title":"Curr Oncol Rep"},{"key":"6290_CR6","first-page":"175","volume":"1","author":"L Balducci","year":"2003","unstructured":"Balducci L. Management of cancer pain in geriatric patients. J Support Oncol. 2003;1:175\u201391.","journal-title":"J Support Oncol"},{"issue":"4","key":"6290_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/jir.12355","volume":"61","author":"A Amor-Salamanca","year":"2017","unstructured":"Amor-Salamanca A, Menchon JM. Pain underreporting associated with profound intellectual disability in emergency departments. J Intellect Disabil Res. 2017;61(4):341\u20137.","journal-title":"J Intellect Disabil Res"},{"issue":"Suppl","key":"6290_CR8","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/1097-0142(19841201)54:2+<2635::AID-CNCR2820541407>3.0.CO;2-P","volume":"54","author":"CS Cleeland","year":"1984","unstructured":"Cleeland CS. The impact of pain on the patient with Cancer. Cancer. 1984;54(Suppl):2635\u201341.","journal-title":"Cancer"},{"issue":"1","key":"6290_CR9","first-page":"67","volume":"9","author":"AA Che Badariah","year":"2010","unstructured":"Che Badariah AA, Shamsul KH. Non-verbal pain assessment: a literature review. Int Med J Malaysia. 2010;9(1):67\u201372.","journal-title":"Int Med J Malaysia"},{"issue":"6","key":"6290_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.iccn.2010.08.007","volume":"26","author":"M Arif-Rahu","year":"2010","unstructured":"Arif-Rahu M. Facial expression and pain in the critically ill non-communicative patient: state of science review. Intensive Crit Care Nurs. 2010 Dec;26(6):343\u201352.","journal-title":"Intensive Crit Care Nurs"},{"issue":"6","key":"6290_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2217\/nmt-2016-0033","volume":"6","author":"S Chow","year":"2016","unstructured":"Chow S, Chow R, Lam M, et al. Pain assessment tools for older adults with dementia in long-term care facilities: a systematic review. Neurodegenerative Dis Manag. 2016;6(6):525\u201338.","journal-title":"Neurodegenerative Dis Manag"},{"issue":"1","key":"6290_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004 Jan;57(1):6\u201314.","journal-title":"Br J Clin Pharmacol"},{"key":"6290_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2165\/00002512-200724090-00004","volume":"24","author":"S Mercadante","year":"2007","unstructured":"Mercadante S, Arcuri E. Drugs Aging. 2007;24:761.","journal-title":"Drugs Aging"},{"issue":"1","key":"6290_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ddrr.1123","volume":"18","author":"AM Coppus","year":"2013","unstructured":"Coppus AM. People with intellectual disability: what do we know about adulthood and life expectancy? Dev Disabil Res Rev. 2013;18(1):6\u201316.","journal-title":"Dev Disabil Res Rev"},{"key":"6290_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1046\/j.1365-2788.2001.00322.x","volume":"45","author":"K Patja","year":"2001","unstructured":"Patja K, Eero P, Iivanainen M. Cancer incidence among people with intellectual disability. J Intellect Disabil Res. 2001;45:300\u20137.","journal-title":"J Intellect Disabil Res"},{"key":"6290_CR16","first-page":"30","volume":"45","author":"K Patja","year":"2001","unstructured":"Patja K, M\u00f6ls\u00e4 P, Iivanainen M. Cause-specific mortality of people with intellectual disability in a population-based, 35-year follow-up study. J Intellect Disabil Res. 2001;45:30\u201340.","journal-title":"J Intellect Disabil Res"},{"key":"6290_CR17","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10552-004-1256-0","volume":"15","author":"SG Sullivan","year":"2004","unstructured":"Sullivan SG, Hussain R, Threlfall T, Bittles AH. The incidence of cancer in people with intellectual disabilities. Cancer Causes Control. 2004;15:1021\u20135.","journal-title":"Cancer Causes Control"},{"key":"6290_CR18","first-page":"215","volume":"3","author":"R Kiani","year":"2010","unstructured":"Kiani R, Tyrer F, Shaikh A, Satg\u00e9 D. Cancer deaths in people with moderate to profound intellectual disabilities: the Leicestershire experience 1993-2006. Int J Child Health Hum Dev. 2010;3:215\u201321.","journal-title":"Int J Child Health Hum Dev"},{"issue":"1","key":"6290_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/jir.12314","volume":"61","author":"G Glover","year":"2017","unstructured":"Glover G, Williams R, Heslop P, Oyinlola J, Grey J. Mortality in people with intellectual disabilities in England. J Intellect Disabil Res. 2017;61(1):62\u201374.","journal-title":"J Intellect Disabil Res"},{"issue":"8","key":"6290_CR20","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.2105\/AJPH.2016.303240","volume":"106","author":"FJ Hosking","year":"2016","unstructured":"Hosking FJ, Carey IM, Shah SM, Harris T, DeWilde S, Beighton C, Cook DG. Mortality among adults with intellectual disability in England: comparisons with the general population. Am J Public Health. 2016 Aug;106(8):1483\u201390.","journal-title":"Am J Public Health"},{"issue":"1","key":"6290_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12877-017-0665-3","volume":"17","author":"N Ng","year":"2017","unstructured":"Ng N, Flygare Wall\u00e9n E, Ahlstr\u00f6m G. Mortality patterns and risk among older men and women with intellectual disability: a Swedish national retrospective cohort study. BMC Geriatr. 2017;17(1):269.","journal-title":"BMC Geriatr"},{"issue":"4","key":"6290_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/jir.12020","volume":"58","author":"L Findlay","year":"2014","unstructured":"Findlay L, Williams AC, Scior K. Exploring experiences and understandings of pain in adults with intellectual disabilities. J Intellect Disabil Res. 2014;58(4):358\u201367.","journal-title":"J Intellect Disabil Res"},{"key":"6290_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/YCO.0b013e32835fd74c","volume":"26","author":"BE McGuire","year":"2013","unstructured":"McGuire BE, Kennedy S. Pain in people with an intellectual disability. Curr Opin Psychiatry. 2013;26:270\u20135.","journal-title":"Curr Opin Psychiatry"},{"key":"6290_CR24","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1111\/j.1365-2702.2012.04269.x","volume":"22","author":"K McKenzie","year":"2013","unstructured":"McKenzie K, Smith M, Purcell AM. The reported expression of pain and distress by people with an intellectual disability. J Clin Nurs. 2013;22:1833\u201342.","journal-title":"J Clin Nurs"},{"key":"6290_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jpain.2013.04.016","volume":"14","author":"NC De Knegt","year":"2013","unstructured":"De Knegt NC, Pieper MJC, Lobbezoo F, Schuengel C, Evenhuis HM, Passchier J, et al. Behavioral pain indicators in people with intellectual disabilities: a systematic review. Journal of Pain. 2013;14:885\u201396.","journal-title":"Journal of Pain"},{"key":"6290_CR26","doi-asserted-by":"publisher","unstructured":"Millard SK, de Knegt NC. Cancer pain in people with intellectual disabilities: systematic review and survey of health care professionals. J Pain Symtom Manage. 2019;19. \n                    https:\/\/doi.org\/10.1016\/j.jpainsymman\n                    \n                   [Epub ahead of print].","DOI":"10.1016\/j.jpainsymman"},{"key":"6290_CR27","unstructured":"SFS1993:387. Act Concerning Support and Service for Persons with Certain Functional Impairments [In Swedish: Lag om st\u00f6d och service till vissa funktionshindrade]. Stockholm;Sweden;1993."},{"key":"6290_CR28","unstructured":"The Swedish National Board of Health and Welfare. Reporting to the National Board of Health and Welfare's patient register: clarification of regulations concerning the obligation to provide information to the patient register - SOSFS 2013:30 [In Swedish: Inrapportering till Socialstyrelsens patientregister: f\u00f6rtydligande till f\u00f6reskrifter om uppgiftsskyldighet till patientregistret. Stockholm;Sweden;2016."},{"issue":"7","key":"6290_CR29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundstr\u00f6m A, Westerholm B, Ros\u00e9n M. The new Swedish prescribed drug register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6290_CR30","unstructured":"Axmon A, Sandberg M, Satg\u00e9 D, Tr\u00e9tarre B, Alstr\u00f6m G. Cancer diagnoses among older people with intellectual disability in Sweden. Second International Symposium on Cancer in Persons with Intellectual Disability, 10\u201312 October 2018 Montpellier."},{"issue":"1","key":"6290_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40360-017-0174-1","volume":"18","author":"A Axmon","year":"2017","unstructured":"Axmon A, Sandberg M, Ahlstr\u00f6m G, Midl\u00f6v P. Prescription of potentially inappropriate medications among older people with intellectual disability: a register study. BMC Pharmacol Toxicol. 2017;18(1):68.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"6","key":"6290_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199218","volume":"13","author":"A Axmon","year":"2018","unstructured":"Axmon A, Sandberg M, Ahlstr\u00f6m G, Midl\u00f6v P. Fall-risk-increasing drugs and falls requiring health care among older people with intellectual disability in comparison with the general population: a register study. PLoS One. 2018 Jun 19;13(6):e0199218. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0199218\n                    \n                  .","journal-title":"PLoS One"},{"issue":"2","key":"6290_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/healthcare6020067","volume":"6","author":"Anna Axmon","year":"2018","unstructured":"Axmon A, Ahlstr\u00f6m G, Westergren H. Pain and Pain Medication among Older People with Intellectual Disabilities in Comparison with the General Population. Healthcare (Basel). 2018;6(2). \n                    https:\/\/doi.org\/10.3390\/healthcare6020067\n                    \n                  .","journal-title":"Healthcare"},{"key":"6290_CR34","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009 Aug;57(8):1331\u201346.","DOI":"10.1111\/j.1532-5415.2009.02376.x"},{"issue":"5","key":"6290_CR35","doi-asserted-by":"publisher","first-page":"821","DOI":"10.18433\/J3VW2F","volume":"16","author":"S Harirforoosh","year":"2013","unstructured":"Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013;16(5):821\u201347.","journal-title":"J Pharm Pharm Sci"},{"key":"6290_CR36","doi-asserted-by":"publisher","unstructured":"Cooper SA, McLean G, Guthrie B, McConnachie A, Mercer S, Sullivan F, Morrison J. Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis. BMC Fam Pract. 2015;16:110. \n                    https:\/\/doi.org\/10.1186\/s12875-015-0329-3\n                    \n                  .","DOI":"10.1186\/s12875-015-0329-3"},{"key":"6290_CR37","unstructured":"Sullivan WF, Diepstra H, Heng J, Ally S, Bradley E, Casson I, Hennen B, et al. Primary care of adults with intellectual and developmental disabilities. 2018 Canadian consensus guidelines. Canadian Family Physician. 2018;64(4):254\u201379."},{"issue":"8","key":"6290_CR38","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00127-019-01695-w","volume":"54","author":"A Axmon","year":"2019","unstructured":"Axmon A, Ahlstr\u00f6m G, Gagnemo Persson R, Eberhard J. Demographic and diagnostic profiles of older people with intellectual disability and prescription of antipsychotics. Soc Psychiatry Epidemiol. 2019;54(8):937\u201344. \n                    https:\/\/doi.org\/10.1007\/s00127-019-01695-w\n                    \n                  .","journal-title":"Soc Psychiatry Epidemiol"},{"key":"6290_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12875-016-0482-3","volume":"17","author":"K Voigt","year":"2016","unstructured":"Voigt K, Gottschall M, Koberlein-Neu J, Schubel J, Quint N, Bergmann A. Why do family doctors prescribe potentially inappropriate medication to elderly patients? BMC Fam Pract. 2016;17:93.","journal-title":"BMC Fam Pract"},{"key":"6290_CR40","doi-asserted-by":"crossref","unstructured":"Axmon A, Bj\u00f6rne P, Nylander L, Ahlstr\u00f6m G. Psychiatric diagnoses in older people with intellectual disability in comparison with the general population: a register study. Epidemiol Psychiatr Sci. 2017;Feb.23:1\u201313.","DOI":"10.1186\/s12888-016-1094-0"},{"key":"6290_CR41","doi-asserted-by":"publisher","unstructured":"Dillane I, Doody O. Nursing people with intellectual disability and dementia experiencing pain: An integrative review. J Clin Nurs. 2019; Jul.28:2472\u201385. doi: \n                    https:\/\/doi.org\/10.1111\/jocn.14834\n                    \n                  .","DOI":"10.1111\/jocn.14834"},{"issue":"3","key":"6290_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00228-012-1387-2","volume":"69","author":"RE Hubbard","year":"2013","unstructured":"Hubbard RE, O'Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol. 2013;69(3):319\u201326.","journal-title":"Eur J Clin Pharmacol"},{"key":"6290_CR43","doi-asserted-by":"crossref","unstructured":"Maust DT, Kales HC, Wiechers IR, Blow FC, Olfson M. No End in Sight: Benzodiazepine Use in Older Adults in the United States. J Am Geriatr Soc. 2016:n\/a-n\/a.","DOI":"10.1111\/jgs.14379"},{"key":"6290_CR44","unstructured":"National Board of Health and Welfare. Interventions for women and men with disabilities. Support for women and men with disabilities [In Swedish: Insatser till kvinnor och m\u00e4n med funktionsneds\u00e4ttning: Support for women and men with disabilities]. ]. National Board of Health and Welfare, Sweden. 2011."},{"issue":"21","key":"6290_CR45","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003737","volume":"95","author":"J Bourke","year":"2016","unstructured":"Bourke J, de Klerk N, Smith T, Leonard H. Population-based prevalence of intellectual disability and autism spectrum disorders in Western Australia: a comparison with previous estimates. Medicine (Baltimore). 2016;95(21):e3737.","journal-title":"Medicine (Baltimore)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6290-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6290-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6290-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:20:26Z","timestamp":1604362826000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6290-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6290"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6290-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"28 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was obtained from the Regional Ethical Review Board in Lund (Swedish government agency) (Ref. No. 2013\/15). The government authorities responsible for national registers don\u2019t provide personal identification numbers to researchers for research studies. This meant that it was no possibility to obtain informed written consent from the participants in this study. Instead, the Ethical Review Board took its decision based on an active refusal from the participants described as follows. According to the demands were the information about the planned study and how to withdraw from this study advertised in two major newspapers in Sweden. One of which was a widespread national public newspaper and the other a national newspaper \u201cUnik\u201d distributed by the Swedish National Association for Persons with Intellectual Disability (FUB) and supporting members.In the next step, permission was needed to access the data from the two register holders. The National Board of Health and Welfare and Statistics Sweden each performed separate secrecy reviews in 2014 before providing access to the data. All analyses were performed using anonymized datasets.The authors assert that all procedures contributing to this work complied with the ethical standards of the relevant national and institutional committees on human experimentation and with the revised version of the Helsinki Declaration from 2008.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1040"}}